|Chemical and physical data|
|Molar mass||395.433 g·mol−1|
|3D model (JSmol)|
FDU-PB-22 is an derivative of JWH-018 that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.
FDU-PB-22 acts as a full agonist with a binding affinity of 1.19nM at CB1 and 2.43nM at CB2 cannabinoid receptors.
FDU-PB-22 is a controlled substance in Germany and is banned in Japan and Sweden.